SCHEMBL2424940

SCHEMBL2424940

COC(=O)c1cccc2c1C(=O)NC2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
HSD17B10 Q99714 2/20 0.54
GAA P10253 1/20 0.54
MAPT P10636 3/20 0.51
MEN1 O00255 2/20 0.51
TSHR P16473 2/20 0.51
KMT2A Q03164 2/20 0.51
HTT P42858 1/20 0.51
MAPK10 P53779 1/20 0.51
PTK2B Q14289 1/20 0.51
NCOA1 Q15788 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
CASP3 P42574 3/20 0.51
GSK3B P49841 2/20 0.50
PDK2 Q15119 1/20 0.50
ROCK2 O75116 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2823345 0.85 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL543980 0.83 MEN1 (0.55) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL5128860 0.81 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL11358929 0.80 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL70816 0.80 TSHR (0.62) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL70284 0.80 MAPT (0.67) KDM4EALDH1A1HSD17B10MAPTMEN1
SCHEMBL69292 0.79 MAPT (0.61) ALDH1A1HSD17B10MAPTMEN1TSHR
SCHEMBL439731 0.79 LIG1 (0.56) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL11782331 0.78 TSHR (0.59) KDM4EALDH1A1HSD17B10MAPTTSHR
SCHEMBL6760793 0.77 MAPT (0.59) ALDH1A1HSD17B10MAPTMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013142093-A1 METHOD FOR THE SYNTHESIS OF DROXIDOPA CHELSEA THERAPEUTICS, INC. (US) 2013-09-26 WO claimed
EP-2542527-A2 PROCESS FOR THE PREPARATION OF ATAZANAVIR SULFATE SUBSTANTIALLY FREE OF DIASTEREOMERS Lupin Limited (IN) 2013-01-09 EP claimed
WO-2011107843-A2 PROCESS FOR THE PREPARATION OF ATAZANAVIR SULFATE SUBSTANTIALLY FREE OF DIASTEREOMERS LUPIN LIMITED (IN) 2011-09-09 WO claimed
CN-106660032-A Solid acid catalyst and method for producing oxide 株式会社大赛璐 2017-05-10 CN disclosed
CN-106660910-A OXIDATION REACTOR AND PROCESS FOR PRODUCING OXIDE 公立大学法人大阪府立大学 2017-05-10 CN disclosed
CN-106573858-A Oxidation reactor and production method for oxide 株式会社大赛璐 2017-04-19 CN disclosed
WO-2013142093-A1 METHOD FOR THE SYNTHESIS OF DROXIDOPA CHELSEA THERAPEUTICS, INC. (US) 2013-09-26 WO disclosed
US-4345071-A AZIDOALKYL-HETEROCYCLIC AMIDINE INTERMEDIATES LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) 1982-08-17 US disclosed
US-4229443-A Derivatives of penicillanic acid LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) 1980-10-21 US disclosed